At least now Sto-ks Dig-tal is also echoing my thoughts— currently we have a MC of around $72m
Our Big Bet for NTI“NTI re-rates to a +$500M market cap by successfully advancing one or more of its clinical trial programs through to regulatory approval, partnership/licensing and/or is acquired by a large pharmaceutical company”
Significant Re Rating $80 to $800m, page-2
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
-0.001(1.69%) |
Mkt cap ! $60.00M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.0¢ | 5.8¢ | $16.67K | 280.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 344807 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 128477 | 2 |
View Market Depth
| Last trade - 15.53pm 03/10/2024 (20 minute delay) ? |
| NTI (ASX) Chart |